ecrin-mdr-crcClinical2013Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungColorectal CancerColorectal NeoplasmsLung NeoplasmsColorectal CancerNon-small Cell Lung CancerColorectal NeoplasmsCarcinoma, Non-small-cell LungLung NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2131268United States2Fibroblast Growth Factor Receptor BiomarkersDovitinibAnti-Vascular Endothelial Growth Factor TherapyECRIN MDRCompletedfalseStudy of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal CancerThe purpose of this study is to find out if dovitinib is an effective treatment for patients with advanced lung cancer or advanced colorectal cancer (CRC) who have progressed on anti-vascular endothelial growth factor (VEGF) treatment.2013-02-152131268NCT01676714